SC19-0656 Screening compound: N-{1-[(1-ethyl-1,4,6,7-tetrahydropyrano[4,3-c]pyrazol-3-yl)methyl]-4-piperidyl}-6-methoxynicotinamide

SC19-0656 Screening compound: N-{1-[(1-ethyl-1,4,6,7-tetrahydropyrano[4,3-c]pyrazol-3-yl)methyl]-4-piperidyl}-6-methoxynicotinamide
SC19-0656 Screening compound: N-{1-[(1-ethyl-1,4,6,7-tetrahydropyrano[4,3-c]pyrazol-3-yl)methyl]-4-piperidyl}-6-methoxynicotinamide alternative view

Chemical Structure Depiction of ChemDiv screening compound SC19-0656
N-{1-[(1-ethyl-1,4,6,7-tetrahydropyrano[4,3-c]pyrazol-3-yl)methyl]-4-piperidyl}-6-methoxynicotinamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SC19-0656

Molecular Formula

C21H29N5O3 (C21 H29 N5 O3)

Compound Name

N-{1-[(1-ethyl-1,4,6,7-tetrahydropyrano[4,3-c]pyrazol-3-yl)methyl]-4-piperidyl}-6-methoxynicotinamide

IUPAC name

N-[1-({1-ethyl-1H4H6H7H-pyrano[43-c]pyrazol-3-yl}methyl)piperidin-4-yl]-6-methoxypyridine-3-carboxamide

SMILES

CCn1nc(CN(CC2)CCC2NC(c(cc2)cnc2OC)=O)c2c1CCOC2

InChI

InChI=1S/C21H29N5O3/c1-3-26-19-8-11-29-14-17(19)18(24-26)13-25-9-6-16(7-10-25)23-21(27)15-4-5-20(28-2)22-12-15/h4-5,12,16H,3,6-11,13-14H2,1-2H3,(H,23,27)

InChI Key

JBVARAGIOUQHJS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD32255568

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

399.49

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.908

Distribution Coefficient, logD

-4.582

Water Solubility, LogSw

-1.97

Polar Surface Area

67.778

Acid Dissociation Constant (pKa)

14.80

Base Dissociation Constant (pKb)

12.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.14

SC19-0656 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

GABA Library (7115 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with SC19-0656 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SC19-0656?
Check Price and Availability of SC19-0656, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SC19-0656 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SC19-0656
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SC19-0656
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SC19-0656 available by request